孟山都起诉新冠疫苗生产商,声称侵犯版权。
Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement

原始链接: https://www.zerohedge.com/medical/monsanto-sues-covid-19-vaccine-manufacturers-alleging-copyright-infringement

拜耳及其旗下的孟山都公司正在起诉辉瑞、BioNTech、莫德纳和强生,指控其侵犯了与新冠疫苗相关的专利。诉讼声称,这些疫苗制造商使用了孟山都公司在1980年代最初为植物生物技术开发的技術——具体而言,增强辉瑞/BioNTech和莫德纳疫苗中的mRNA稳定性,以及改善强生疫苗中的DNA递送。 拜耳表示,他们并非寻求停止疫苗生产,而是希望就“侵权”行为获得经济赔偿,这些侵权行为使这些公司获得了数十亿美元的收入。尽管强生疫苗已停产,但辉瑞、BioNTech和莫德纳正在抗辩这些指控。 这并非首次与新冠疫苗相关的诉讼;莫德纳此前曾起诉辉瑞侵犯专利权,英国法院最近在一宗类似的辉瑞诉莫德纳案件中判决莫德纳胜诉。拜耳寻求赔偿,包括合理的特许权使用费和利息,以弥补据称对其专利技术的未经授权使用。

相关文章

原文

Authored by Zachary Stieber via The Epoch Times,

Bayer and its Monsanto division are suing COVID-19 vaccine manufacturers, alleging they used technology Monsanto developed and patented in the 1980s in their vaccines.

Bayer said in lawsuits that Pfizer, its partner BioNTech, and Moderna wrongly used technology Monsanto developed and used to make plants resistant to insects.

Pfizer-BioNTech and Moderna included the technology in their shots to enhance the stability of messenger ribonucleic acid (mRNA) “and thus the vaccines’ ability to confer immunity to the virus,” lawyers for Bayer and Monsanto said in the suits, which were filed on Jan. 6 with the U.S. court in Delaware.

Bayer was not involved in COVID-19 vaccine manufacturing or production.

Bayer said it was not seeking to interfere with the production of the COVID-19 vaccines, which are still being made and sold, but said the court should award it money, describing the defendants as having “profited handsomely from infringing vaccine sales worldwide.”

“Plaintiffs are entitled to damages as a result of Defendants’ infringement of the ... Patent in an amount yet to be determined and adequate to compensate Plaintiffs for Defendants’ infringement, but in no event less than a reasonable royalty for the use made of the patented invention by Defendants, together with interest and costs as fixed by the Court,” with the exception of acts of infringement covered by one federal law, the filings state.

Pfizer, BioNTech, and Moderna earned billions of dollars from their vaccines against COVID-19 during the pandemic, according to company reports. Pfizer, for example, reported making $11.2 billion in 2023 from its shot.

“BioNTech is aware that Bayer and Monsanto have filed an action for infringement with respect to one patent against Pfizer and BioNTech,” a spokesperson for BioNTech told The Epoch Times in an email. The company declined further comment.

“Moderna is aware of the litigation and will defend ourselves against these claims,” a spokesman for Moderna told The Epoch Times via email.

Pfizer did not return an inquiry.

In a third lawsuit, lodged in federal court in New Jersey, Bayer said Johnson & Johnson also infringed on a patent with its COVID-19 vaccine, which did not utilize mRNA.

That complaint said Johnson & Johnson’s vaccine, which delivered DNA to a recipient’s cells to trigger protection, would not have been effective without the patented sequence and template that Bayer developed and patented.

Johnson & Johnson’s vaccine was withdrawn from the market in 2023. Johnson & Johnson did not respond to a request for comment.

The new complaints are the latest over the COVID-19 vaccines. Other suits have involved Pfizer and Moderna, including a suit brought by Moderna against Pfizer.

A court in England ruled in 2024 that Pfizer infringed on a Moderna patent.

Loading recommendations...

联系我们 contact @ memedata.com